Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
US7473790B2 · kind B2 · utility
0Cited by
16References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 8, 2006 |
| Grant date | Jan 6, 2009 |
| Priority date | — |
| Expiry date | Aug 23, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to compounds of the formula 1and to pharmaceutically acceptable salts, solvates, prodrugs and metabolites thereof, wherein W, Z, R1 and R2, are as defined herein. The invention also relates to methods of treating Hepatitis C virus in mammals by administering the compounds of formula 1, and to pharmaceutical compositions for treating such disorders, which contain the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.